ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 65 filers reported holding ARGENX SE in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,839,679 | +395.9% | 3,742 | +253.7% | 0.05% | +100.0% |
| Q4 2021 | $371,000 | -51.1% | 1,058 | -58.0% | 0.02% | -64.1% |
| Q2 2021 | $758,000 | +102.1% | 2,518 | +7.8% | 0.06% | +190.9% |
| Q4 2019 | $375,000 | +4.2% | 2,336 | -8.2% | 0.02% | -31.2% |
| Q2 2019 | $360,000 | +73.9% | 2,546 | +17.9% | 0.03% | +146.2% |
| Q4 2018 | $207,000 | -7.2% | 2,159 | -38.8% | 0.01% | -45.8% |
| Q4 2017 | $223,000 | – | 3,530 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |